Company intelligence / Profile preview
Neela Therapeutics
Lunenburg, Massachusetts, USAneelatx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Neela Therapeutics is a clinical-stage biotechnology company dedicated to advancing precision therapies for rare pediatric neuro-genetic diseases. Established in 2025 as a spin-out from Alcyone Therapeutics following Biogen's acquisition of Alcyone, the company focuses on delivering transformative treatments for complex central nervous system conditions. Neela's lead program, CLN-301, is an AAV9-based gene therapy currently in Phase 1/2 clinical trials for CLN3 Batten disease. The company leverages proprietary platforms including Falcon for precision CNS drug delivery, miREX for X-chromosome reactivation, and Efralex for targeting neurodegenerative pathways.
- Therapeutic areas
- NeurologyRare Diseases
- Modalities
- Gene therapySmall moleculeAAV9Precision drug delivery
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Nationwide Children's Hospital
Beyond the preview
Go deeper on Neela Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neela Therapeutics.